Akka has not provided a guidance for 2020. The company expects to suffer in H1, from automotive, aerospace and Covid-19

Akka has not provided a guidance for 2020. The company expects to suffer in H1, from automotive, aerospace and Covid-19
2018 was an eventful year: the top ER&D vendors accelerated their M&A activities. Alten continued to deploy its business model. HCL Tech’s ERS unit had a superb year